CEDARS SINAI MEDICAL CENTER reported 5 transactions at PROMETHEUS BIOSCIENCES, INC.
Review the transaction codes below to understand the nature of each event.
Common Stock
Shares
+100K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.20M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+2.50M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+254.44K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+361.57K
Price / share
—
Trade value
—
% of position
Net shares
+4.42M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2021 | C · Conversion | +100K | — | — | 16.9% | 592.50K | 692.50K |
| Common Stock Direct | 3/16/2021 | C · Conversion | +1.20M | — | — | 173.3% | 692.50K | 1.89M |
| Common Stock Direct | 3/16/2021 | C · Conversion | +2.50M | — | — | 132.1% | 1.89M | 4.39M |
| Common Stock Direct | 3/16/2021 | C · Conversion | +254.44K | — | — | 5.8% | 4.39M | 4.65M |
| Common Stock Direct | 3/16/2021 | C · Conversion | +361.57K | — | — | 7.8% | 4.65M | 5.01M |
| Total | +4.42M | $0.00 | ||||||
Series A Preferred Stock
Common Stock
100K shares
Shares
−1M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.20M shares
Shares
−12M
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
2.50M shares
Shares
−25M
Strike price
Held after
0.00
Exercisable
—
Series D-1 Preferred Stock
Common Stock
254.44K shares
Shares
−2.54M
Strike price
Held after
0.00
Exercisable
—
Series D-2 Preferred Stock
Common Stock
361.57K shares
Shares
−3.62M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock100K shares | 3/16/2021 | C · Conversion | −1M | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock1.20M shares | 3/16/2021 | C · Conversion | −12M | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock2.50M shares | 3/16/2021 | C · Conversion | −25M | — | 0.00 | |
| Series D-1 Preferred Stock Direct | Common Stock254.44K shares | 3/16/2021 | C · Conversion | −2.54M | — | 0.00 | |
| Series D-2 Preferred Stock Direct | Common Stock361.57K shares | 3/16/2021 | C · Conversion | −3.62M | — | 0.00 |